Cite
Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma.
MLA
Greco, Francesco, and Vincenzo Mirone. “Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma.” European Urology, vol. 68, no. 2, Aug. 2015, p. 336. EBSCOhost, https://doi.org/10.1016/j.eururo.2015.03.012.
APA
Greco, F., & Mirone, V. (2015). Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma. European Urology, 68(2), 336. https://doi.org/10.1016/j.eururo.2015.03.012
Chicago
Greco, Francesco, and Vincenzo Mirone. 2015. “Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma.” European Urology 68 (2): 336. doi:10.1016/j.eururo.2015.03.012.